Pricing Log in Create free account

ADARx Pharmaceuticals, Inc. (ADRX) vs Sarepta Therapeutics, Inc. (SRPT)

ADARx Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. are of similar size ($2.0B and $1.9B).

Valuation

Metric ADRX SRPT Biotechnology median
P/E — n/m 8.58
P/S — 0.97 10.29
P/B — 1.26 2.29
Price to free cash flow — 25.59 21.93
EV/EBITDA — n/m 0.67
EV/Sales — 1.05 9.89
Earnings yield — (7.93%) (31.56%)
Free cash flow yield — 3.91% (23.42%)

Profitability

Metric ADRX SRPT Biotechnology median
Gross margin — 59.09% 65.77%
Operating margin — (7.26%) 0.00%
Net margin — (6.93%) 0.00%
Free cash flow margin — 3.80% 0.00%
Return on equity — (9.48%) (54.09%)
Return on assets — (3.98%) (47.78%)
Return on invested capital — (5.64%) 0.00%

Growth

Metric ADRX SRPT Biotechnology median
Revenue growth (TTM) — (20.44%) 5.83%
EPS growth (last fiscal year) — (404.70%) 29.36%
Revenue growth, 5-year CAGR — 32.41% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADRX SRPT Biotechnology median
Debt to equity — 0.55 0.00
Current ratio — 4.42 4.80
Net debt to EBITDA — 0.17 0.97

Dividend

Metric ADRX SRPT Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric ADRX SRPT Biotechnology median
Market cap 1.90b 1.96b 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack